STOCK TITAN

LadRx (CYTR) Stock Price, News & Analysis

CYTR
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
94 192 sessions, December 31, 2021 to October 5, 2022
Largest daily move
-34.4% close of April 18, 2022
1-month change
+16.2% closing prices, September 2, 2022 to October 5, 2022

Company Description

LadRx (OTC: CYTR) is classified in the biotechnology industry within the Healthcare sector.

CYTR declined 81.8% in the year to October 5, 2022. The last closing price was $0.0920.

This page collects what Stock Titan holds for CYTR, including price data and latest news.

Stock Performance

$0.0920
No recent trading
Last close: October 5, 2022
-81.8%
Year to October 5, 2022

LadRx (CYTR) closed at $0.0920 on October 5, 2022. In the year to October 5, 2022, the price lost 81.8%.

See what a $1,000 investment in CYTR would be worth today

Average down calculator for CYTR

CYTR Metrics & Rankings

Price returns through October 5, 2022. Month and year figures include the first trading day. Ranking links may use different dates.

SEC Filings

No SEC filings available for CYTR.

CYTR Company Profile & Sector Positioning

LadRx (CYTR) operates in the Biotechnology industry within the broader Healthcare sector.

Investors comparing CYTR often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CYTR's relative position within its industry.

Frequently Asked Questions

LadRx (CYTR) has no recent trading. Its last close was $0.0920 on October 5, 2022.